Addressing the Rising Challenge of West Nile Virus: Insights from Sheba Medical Experts
The ongoing outbreak of West Nile virus has been the most significant the country has seen in years. In addition to the large number of cases, with most severe patients being over the age of 70, another unusual fact was that it occurred earlier than it usually does during the year.
Featured in the news segment was Shilo Miller, who was hospitalized at Sheba Medical Center after beginning to show flu-like symptoms. Soon after arriving and being diagnosed with West Nile virus, his condition deteriorated, at one point requiring two resuscitations, and he was transferred to the intensive care unit.
SPRI’s Efforts to Combat West Nile Virus
Prof. Gili Regev-Yochay, Director of The Sheba Pandemic Preparedness Research Institute (SPRI), highlighted the department’s efforts, founded after the COVID-19 pandemic, to find a cure for a disease without a vaccine or dedicated treatment.
Sheba has begun exploring antibody therapy from recovered patients, which shows promise in some cases. Among them was Shilo, whose family said that after several weeks, he had regained consciousness and could communicate more with his environment.
Sheba’s Collaboration With the Ministry of Environmental Protection
Another role Sheba plays is cooperating with Israel’s Ministry of Environmental Protection in monitoring mosquito populations through the medical center’s virology lab. This combined effort, as well as the ongoing treatment trials, is crucial for understanding and controlling the outbreak and highlights Sheba’s continuing work as a center for innovation and patient care.


